CERT
Certara, Inc.
CERT lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to hold roughly steady.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
CERT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Healthy | |
| Healthy |
CERT's cash flow and balance sheet are currently healthy, but its revenue and profitability are under pressure.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
CERT PE Valuation
CERT has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
CERT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Stable | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect CERT's profitability to weaken, with its earnings and revenue holding steady.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
CERT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.40 | — |
| Q3 2026 | -$0.42 | -700% |
| Q2 2026 | -$0.45 | -1000% |
| Q1 2026 | -$0.10 | -$0.08 |
| Q4 2025 | -$0.01 | +$0.07 |
| Q3 2025 | $0.07 | +$0.27 |
| Q2 2025 | $0.05 | +$0.55 |
| Q1 2025 | -$0.02 | +$0.37 |
| Q4 2024 | -$0.08 | +$0.27 |
CERT has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
CERT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $94.9M | -9.3% |
| Q2 2026 | $93.3M | -11% |
| Q1 2026 | $106.9M | +0.9% |
| Q4 2025 | $103.6M | +3.3% |
| Q3 2025 | $104.6M | +10% |
| Q2 2025 | $104.6M | +12% |
| Q1 2025 | $106M | +9.7% |
| Q4 2024 | $100.4M | +14% |
CERT's revenue is shrinking: $95M last quarter, down 9.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.5% | -0.4 points |
| Q2 2026 | -0.2% | -9.3 points |
| Q1 2026 | -4% | -11 points |
| Q4 2025 | 0.8% | -5.2 points |
| Q3 2025 | 2.9% | +0.1 points |
| Q2 2025 | 9.1% | +19 points |
| Q1 2025 | 7.2% | +8.5 points |
| Q4 2024 | 6% | +16 points |
CERT has the edge over HIMS on profitability, with a higher operating margin.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over CERT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
CERT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $29.9M | -6.8% |
| Q2 2026 | $9.4M | -47% |
| Q1 2026 | $11.1M | -34% |
| Q4 2025 | $27.8M | -43% |
| Q3 2025 | $32.1M | +91% |
| Q2 2025 | $17.9M | +91% |
| Q1 2025 | $16.8M | +356% |
| Q4 2024 | $49M | +118% |
CERT's free cash flow has been positive every quarter for seven years: $78M over the past year, down 32% from the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over CERT on cash flow, with more consistent year-over-year improvement.
CERT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.1% | -1.7M shares |
| 1 year | -4.9% | -7.9M shares |
| 3 years | -4.1% | -6.5M shares |
| 5 years | +2.5% | +3.7M shares |
| Available history | +3.8% | +5.5M shares |
CERT has 153M diluted shares, down 4.9% from a year ago, with $61M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $17.4M |
| Q1 2026 | $40M |
| Q4 2025 | $3.9M |
| Q3 2025 | $13.7M |
| Q4 2020 | — |
| Q3 2020 | $1M |
| Q2 2020 | — |
CERT spent $61M buying back its own shares over the past year.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over CERT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
CERT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.3x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 2.2x | Moderate |
| Q2 2025 | 3.2x | Elevated |
| Q1 2025 | 12.0x | High |
| Q4 2024 | 442.0x | High |
CERT's net debt is about 1.3 years of its operating earnings (EBITDA), down from 2.2 years a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
CERT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.4 | Overbought |
| Stochastic | 88.2 | Overbought |
CERT's weekly RSI is 74 (overbought) and its Stochastic is 88 (overbought).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
CERT PE vs Healthcare Sector
| Metric | CERT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
CERT has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
CERT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.3 | 16% above |
| 20 week MA | $8.77 | 36% above |
| 50 week MA | $7.68 | 55% above |
| 100 week MA | $9.56 | 24% above |
| 200 week MA | $13.0 | 8.2% below |
CERT has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
CERT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $38.1 | $37.8 | -0.7% |
| 2021 | $37.8 | $29.4 | -22% |
| 2022 | $29.4 | $16.0 | -45% |
| 2023 | $16.0 | $17.6 | +9.8% |
| 2024 | $17.6 | $10.7 | -39% |
| 2025 | $10.7 | $8.89 | -17% |
| 2026 YTD | $8.89 | $11.9 | +34% |
CERT has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.